Skip to content

Effect of Agnikarma to treat the pain of calcaneal spur

Clinical validation of Agnikarma in pain management of calcaneal spur-a pilot study.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/032760
Enrollment
30
Registered
2021-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: M959- Acquired deformity of musculoskeletal system, unspecified

Interventions

Intervention1: Agnikarma: Dose- 15-30 bindu Agnikarma Frequency - weekly Agnikarma Route of Administration - Locally Duration- 4 week Type of dahanopkarana - Cuppor shalaka Site of Agnikarma - local

Sponsors

CBPACS Khera Dabar New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The common age group of patient selection are 25 years to 50 years. Patient with positive finding of calcaneal spur in the X ray within the preceding one month. The pain at sole region due to calcaneal spur will only be registered. Those patients who ready to give informed consent

Exclusion criteria

Exclusion criteria: Patient having open wound on foot, osteomyelitis, osteoporosis sign, any bony deformity other than calcaneal spur, callosity, flat foot and obesity Any other causes which produce ankle & heal pain like trauma, blunt injury due to fall, fractured bone, malunion of fractured bone, plantar fasciitis, corn etc Age less than 25 years old or older than 50 years old. Immune compromised, diabetes mellitus, diabetic foot, HIV infected, Hepatitis infected Pregnancy, Cardiac disease especially coronary artery disease, Chronic obstructive lung disease Significant renal or liver dysfunction, Seizure disorders, uncontrolled psychosis, thyroid and non-thyroid active cancers, Psychotropic medication use, steroid use, chemotherapy for cancer, who are expected to move out of the geographic area

Design outcomes

Primary

MeasureTime frame
To measure amount of pain relief deliver by AgnikarmaTimepoint: 4 week

Secondary

MeasureTime frame
To improve the quality of life.Timepoint: 4 week

Countries

India

Contacts

Public ContactDR MAHESH KUMAR

CBPACS, Khera Dabar, Najafgarh New Delhi- 73

drmkguptabhu@gmail.com08287794020

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026